Cancel anytime
Materialise NV (MTLS)MTLS
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/07/2024: MTLS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -21.47% | Upturn Advisory Performance 3 | Avg. Invested days: 27 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/07/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -21.47% | Avg. Invested days: 27 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/07/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 372.71M USD |
Price to earnings Ratio 35.06 | 1Y Target Price 10.43 |
Dividends yield (FY) - | Basic EPS (TTM) 0.18 |
Volume (30-day avg) 136616 | Beta 1.11 |
52 Weeks Range 4.70 - 6.93 | Updated Date 11/8/2024 |
Company Size Small-Cap Stock | Market Capitalization 372.71M USD | Price to earnings Ratio 35.06 | 1Y Target Price 10.43 |
Dividends yield (FY) - | Basic EPS (TTM) 0.18 | Volume (30-day avg) 136616 | Beta 1.11 |
52 Weeks Range 4.70 - 6.93 | Updated Date 11/8/2024 |
Earnings Date
Report Date 2024-10-24 | When BeforeMarket |
Estimate 0.03 | Actual 0.05 |
Report Date 2024-10-24 | When BeforeMarket | Estimate 0.03 | Actual 0.05 |
Profitability
Profit Margin 3.75% | Operating Margin (TTM) 6.28% |
Management Effectiveness
Return on Assets (TTM) 3.01% | Return on Equity (TTM) 4.12% |
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 35.06 | Forward PE - |
Enterprise Value 304970918 | Price to Sales(TTM) 1.4 |
Enterprise Value to Revenue 1.07 | Enterprise Value to EBITDA 8.22 |
Shares Outstanding 59067200 | Shares Floating 24819363 |
Percent Insiders 4.09 | Percent Institutions 10.72 |
Trailing PE 35.06 | Forward PE - | Enterprise Value 304970918 | Price to Sales(TTM) 1.4 |
Enterprise Value to Revenue 1.07 | Enterprise Value to EBITDA 8.22 | Shares Outstanding 59067200 | Shares Floating 24819363 |
Percent Insiders 4.09 | Percent Institutions 10.72 |
Analyst Ratings
Rating 5 | Target Price 12.59 | Buy - |
Strong Buy 3 | Hold - | Sell - |
Strong Sell - |
Rating 5 | Target Price 12.59 | Buy - | Strong Buy 3 |
Hold - | Sell - | Strong Sell - |
AI Summarization
Materialise NV: A Detailed Overview
Company Profile:
Detailed History and Background: Founded in 1990 as a spin-off from the University of Leuven in Belgium, Materialise NV is a pioneer in 3D printing software and services. From its early days developing software for rapid prototyping, Materialise has grown into a global leader, offering a broad range of solutions across various sectors.
Description of Core Business Areas:
- Software Solutions: Materialise develops and licenses 3D printing software for various applications, including medical, automotive, aerospace, and consumer products.
- Printing Services: Through their own facilities and a network of partners, Materialise offers 3D printing services using various technologies and materials.
- Medical 3D Printing: Materialise is a major player in the medical 3D printing market, offering software, services, and materials for custom implants, surgical planning, and anatomical models.
- Additive Manufacturing Solutions: Materialise offers consulting, design, and engineering services to help companies integrate additive manufacturing into their production processes.
Overview of Leadership and Corporate Structure:
- Executive Team: The executive team is led by CEO Fried Vancraen, with expertise spanning 3D printing, software development, and business strategy.
- Board of Directors: The board comprises individuals with diverse backgrounds, including entrepreneurs, academics, and industry experts.
- Corporate Structure: Materialise operates through subsidiaries and branches in over 15 countries, employing approximately 1,800 people worldwide.
Top Products and Market Share:
- Magics 3D Print Suite: A comprehensive software platform for preparing, managing, and optimizing 3D printing processes.
- Mimics Innovation Suite: Software for medical image processing, segmentation, and 3D model creation for surgical planning and personalized implants.
- i.materialise: An online platform connecting designers and manufacturers for 3D printing services.
- 3D Printing Services: Materialise offers a wide range of 3D printing services across various technologies and materials, including metal, plastic, and ceramic.
Market Share Analysis:
- Software: Materialise is a leading player in 3D printing software, with a strong market share in the medical and dental segments.
- Services: Materialise is a top-ranked service provider, particularly for complex medical and industrial applications.
- Market Share Comparison: Materialise faces competition from other established companies like 3D Systems, Stratasys, and EOS, with each holding varying strengths in different segments.
Total Addressable Market:
The global additive manufacturing market is estimated to be worth around $15.8 billion in 2023 and is projected to grow at a CAGR of 18.5% to reach $35.6 billion by 2030. The medical, dental, and aerospace segments are expected to be key drivers for growth.
Financial Performance:
Analysis of Recent Financial Statements: (Based on available data, most recent annual report is from 2022)
- Revenue: Revenue for 2022 was €256.7 million, representing a year-on-year increase of 15%.
- Net Income: Net income was €15.8 million in 2022, reflecting an increase of 24% compared to 2021.
- Profit Margins: Profit margins have been improving, with an operating margin of 10.2% and a net margin of 6.2% in 2022.
- Earnings per Share (EPS): EPS for 2022 was €0.36, demonstrating an increase from €0.29 in the previous year.
Financial Performance Comparison:
- Materialise has shown consistent revenue growth over the past years, with an average annual growth rate of 12%.
- Profitability has been steadily improving with increasing profit margins.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Materialise NV
Exchange | NASDAQ | Headquaters | - |
IPO Launch date | 2014-06-25 | CEO | - |
Sector | Technology | Website | https://www.materialise.com |
Industry | Software - Application | Full time employees | 2437 |
Headquaters | - | ||
CEO | - | ||
Website | https://www.materialise.com | ||
Website | https://www.materialise.com | ||
Full time employees | 2437 |
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.